Browsing: Clinical Trials

Johnson & Johnson, which was part of the wave of the first cell therapies, is now getting a next-generation contender…

Processa Pharmaceuticals is reshaping its pipeline with the acquisition of Vidya Therapeutics, a clinical-stage biotech whose main asset is a…

GLP-1 drugs first made their mark in diabetes and obesity, but many research efforts are underway to bring such therapies…

Argenx established itself in immunology with a single drug offering potential use across a range of rare inflammatory disorders. The…

Crystalys Therapeutics does not yet have data from pivotal tests of its gout drug, but the company is already looking…

For many people, managing a disease means chronic therapy. Scribe Therapeutics has a different vision: genetic medicines that offer durable…

A drug included in one of the pharmaceutical industry’s largest acquisitions this year is starting to paying dividends for GSK,…

Agios Pharmaceuticals is stopping development of a drug for sickle cell disease after mid-stage clinical data showed the molecule failed…

Statins are a standard drug for managing high cholesterol, but for patients who need something stronger, a newer class of…

There are no FDA-approved treatments for recurrent chronic cough, and a GSK drug from a $2 billion acquisition just lost…